Ea. Kvittingen et al., HEREDITARY TYROSINEMIA TYPE-I - SELF-INDUCED CORRECTION OF THE FUMARYLACETOACETASE DEFECT, The Journal of clinical investigation, 91(4), 1993, pp. 1816-1821
Two Norwegian patients with chronic tyrosinemia type I showed > 50% re
sidual fumarylacetoacetase activity in liver samples obtained during l
iver transplantation. The enzyme characteristics of both patients were
comparable with those of a normal control. Immunohistochemistry on li
ver sections from these patients and from three other Norwegian tyrosi
nemia patients revealed a mosaicism of fumarylacetoacetase immunoreact
ivity corresponding completely or partly to some of the regenerating n
odules. This appearance of enzyme protein is presumably induced by the
disease process. The mechanism involved remains unclear and could be
caused by a genetic alteration, regained translation of messenger RNA,
or to enhanced stability of an abnormal enzyme.